February 21st, 2017. Halifax-based STI Technologies was acquired by QuintilesIMS (NYSE: Q -), the world’s largest provider of biopharmaceutical development and commercial outsourcing services for an amount reported by Allnovascotia.com to be about $200 million. Founded in 2001, STI received a $17 million investment from Imperial Capital Group to accelerate the Company’s Canadian market-leading intelligent reimbursement card technology.
Source: BetaKit
Transaction Details:
| Date of Announcement | 2/10/2017 | ||
| Headline | Quintiles IMS acquires STI Technologies | ||
| Sector | Pharmaceuticals, Health Care, Biotechnology | ||
| Company Acquired | STI Technologies | ||
| Company Location | Halifax, Nova Scotia | ||
| Private/Public | Private | ||
| Transaction Amount (reported) | N/A | ||
| Founded | 2001 | ||
| Employees | 51-200 | ||
| Amount Invested | US$17M | 1 Round | 1 Investor |
| Key Investors | Imperial Capital Group | ||
| Acquirer | Quintiles IMS | ||
| Acquirer Location | Durham, North Carolina | ||
| Private/Public | Public | ||
| Founded | 1982 | ||
| Employees | 50,000+ | ||
| Capital Raised to date | N/A | ||
| Comment | The combination of QuintilesIMS and STI Technologies' capabilities will enable our customers to deliver a better patient experience. | ||
| Press Release | BetaKit | ||
| Source | crunchbase | ||
| For more information: | Click Here |
